News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
513,222 Results
Type
Article (12115)
Company Profile (164)
Press Release (500941)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (174424)
Career Advice (368)
Deals (26615)
Drug Delivery (17)
Drug Development (55661)
Employer Resources (17)
FDA (10177)
Job Trends (9181)
News (248914)
Policy (18890)
Tag
2027 BioCapital Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (7)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (939)
Accelerated approval (27)
ADA (19)
Adcomms (1)
Allergies (102)
Alliances (36147)
ALS (116)
Alzheimer's disease (1057)
Antibody-drug conjugate (ADC) (291)
Approvals (10820)
Artificial intelligence (433)
ASCO (181)
Autoimmune disease (228)
Automation (42)
Bankruptcy (270)
Best Places to Work (7443)
BIO (40)
Biologics (2)
BIOSECURE Act (13)
Biosimilars (116)
BioSpace Insights (22)
Biotechnology (113)
Bladder cancer (142)
Brain cancer (38)
Breast cancer (581)
Cancer (4199)
Cardiovascular disease (234)
Career advice (309)
Career pathing (4)
CAR-T (213)
CDC (1)
CDMO (25)
Celiac Disease (2)
Cell therapy (580)
Cervical cancer (34)
Clinical research (49974)
Collaboration (1469)
Commercialization (3)
Compensation (1522)
Complete response letters (36)
COVID-19 (968)
CRISPR (103)
C-suite (839)
Cystic fibrosis (91)
Data (6189)
Denatured (4)
Depression (109)
Dermatology (65)
Diabetes (364)
Diagnostics (4885)
Digital health (39)
Diversity (1)
Diversity, equity & inclusion (6)
Drug discovery (202)
Drug pricing (7)
Drug shortages (5)
Duchenne muscular dystrophy (173)
Earnings (75058)
Editorial (2)
Employer branding (3)
Employer resources (17)
Events (91422)
Executive appointments (758)
FDA (12970)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (18)
Frontotemporal dementia (23)
Funding (1053)
Gene editing (198)
Generative AI (16)
Gene therapy (412)
GLP-1 (346)
Government (1239)
Grass and pollen (2)
Guidances (297)
Healthcare (10169)
Hematology (107)
HIV (58)
Huntington's disease (31)
IgA nephropathy (66)
Immunology and inflammation (108)
Immuno-oncology (67)
Indications (165)
Infectious disease (1168)
Inflammatory bowel disease (131)
Inflation Reduction Act (4)
Influenza (87)
Intellectual property (270)
Interviews (46)
IPO (12773)
IRA (2)
Job creations (2098)
Job search strategy (294)
JPM (3)
Kidney cancer (16)
Labor market (5)
Layoffs (74)
Leadership (1)
Legal (5312)
Licensing (15)
Liver cancer (52)
Longevity (21)
Lung cancer (586)
Lymphoma (280)
Machine learning (38)
Management (3)
Manufacturing (617)
Marketing (8)
MASH (124)
Medical device (8931)
Medtech (9084)
Mergers & acquisitions (14930)
Metabolic disorders (755)
mRNA (88)
Multiple sclerosis (107)
NASH (5)
Neurodegenerative disease (241)
Neuropsychiatric disorders (46)
Neuroscience (1983)
NextGen: Class of 2026 (3470)
Non-profit (1119)
Now hiring (6)
Obesity (242)
Opinion (45)
Ovarian cancer (182)
Pain (180)
Pancreatic cancer (222)
Parkinson's disease (217)
Partnered (15)
Patents (514)
Patient recruitment (535)
Peanut (32)
People (43533)
Pharmaceutical (32)
Pharmacy benefit managers (9)
Phase 1 (16362)
Phase 2 (22389)
Phase 3 (15068)
Pipeline (7878)
Policy (38)
Postmarket research (1606)
Preclinical (7053)
Press Release (66)
Prostate cancer (203)
Psychedelics (17)
Radiopharmaceuticals (207)
Rare diseases (669)
Real estate (3287)
Recruiting (6)
Regulatory (15674)
Reports (22)
Research institute (1118)
Resumes & cover letters (48)
Rett syndrome (43)
RNA editing (7)
RSV (48)
Schizophrenia (106)
Series A (181)
Series B (135)
Service/supplier (5)
Sickle cell disease (80)
Spinal muscular atrophy (96)
Sponsored (12)
Startups (2301)
Stomach cancer (3)
Supply chain (58)
Tariffs (1)
Vaccines (380)
Venture capital (23)
Weight loss (85)
Women's health (86)
Date
Today (1)
Last 7 days (447)
Last 30 days (1501)
Last 365 days (20119)
2026 (13782)
2025 (20481)
2024 (24598)
2023 (28355)
2022 (36705)
2021 (39538)
2020 (35549)
2019 (25248)
2018 (18914)
2017 (20441)
2016 (19577)
2015 (25752)
2014 (22658)
2013 (19124)
2012 (21076)
2011 (21339)
2010 (21070)
Location
Africa (289)
Alabama (80)
Alaska (3)
Arizona (317)
Arkansas (11)
Asia (20248)
Australia (2710)
California (12708)
Canada (3278)
China (639)
Colorado (511)
Connecticut (457)
Delaware (214)
Europe (31307)
Florida (1859)
Georgia (389)
Hawaii (4)
Idaho (48)
Illinois (747)
India (57)
Indiana (334)
Iowa (24)
Japan (430)
Kansas (108)
Kentucky (36)
Louisiana (30)
Maine (31)
Maryland (1313)
Massachusetts (8550)
Michigan (323)
Minnesota (591)
Mississippi (4)
Missouri (93)
Montana (22)
Nebraska (14)
Nevada (119)
New Hampshire (66)
New Jersey (2776)
New Mexico (19)
New York (2983)
North Carolina (1362)
North Dakota (9)
Northern California (6392)
Ohio (309)
Oklahoma (14)
Oregon (19)
Pennsylvania (2324)
Puerto Rico (20)
Rhode Island (36)
South America (465)
South Carolina (79)
South Dakota (1)
Southern California (5246)
Tennessee (132)
Texas (2074)
United States (41431)
Utah (379)
Vermont (1)
Virginia (166)
Washington D.C. (42)
Washington State (980)
West Virginia (1)
Wisconsin (87)
Wyoming (1)
513,222 Results for "synthetic genomics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Telo Genomics Provides Positive Interim Data from Ongoing Clinical Trial Advancing Genomic Instability-Based Relapse Risk Assessment
Clinical Study on Track to Meet Primary Endpoints with Interim Data Demonstrating Blood-Based Assay Capable of Predicting Relapse Risk Through Analysis of Genomic Instability and Telomere Architecture
July 16, 2026
·
8 min read
Press Releases
SynGenSys Introduces Expanded CHO.SET Synthetic Promoter Library for Enhanced Biomanufacturing
August 13, 2026
·
2 min read
Press Releases
Moss Genomics Inc. Provides Default Status Disclosure and Update on Continuous Disclosure Review
August 25, 2026
·
4 min read
Press Releases
4basebio and Genezen Enter into Strategic Collaboration to Advance Synthetic, Cell-Free DNA Platforms for Next-Generation Viral Vector Manufacturing
August 26, 2026
·
3 min read
Press Releases
Complete Genomics Appoints Lauren Selig to Board of Directors
August 19, 2026
·
3 min read
Press Releases
Telo Genomics Grants Stock Options
August 4, 2026
·
1 min read
Press Releases
Ecotone AI Breaks the Genomics Cost Barrier, Cutting Genome Processing from $100 to Under $1
New GPU-powered system reduces whole-genome processing time from hours to minutes, unlocking population-scale genetic discovery and accelerating rare disease drug development
February 25, 2026
·
1 min read
Press Releases
10x Genomics Acquires Proteintech Genomics, a Division Within Proteintech Group
June 9, 2026
·
6 min read
Press Releases
Pluristyx Announces Patent Allowance of Next Generation Synthetic mRNA Technology in Japan, Solidifying Global iPSC Reprogramming Leadership
June 16, 2026
·
4 min read
Press Releases
GenomOncology Announces Integrated End-to-End Workflow Using PacBio’s Long-Read Whole-Genome Sequencing Technology in Oncology
July 30, 2026
·
3 min read
1 of 51,323
Next
